Objective: The absence of a standardized recording technique and of normal reference patterns may have hindered the use of experimental electroencephalography (EEG) in dogs and in veterinary medicine as well. Therefore, the aim of the present work was to develop a recording technique for brachycephalic, mesocephalic and dolichocephalic breeds of dogs that would standardize the recording parameters, including the electrical activity of the rhinencephalon and prorean gyrus, and to prove its feasibility for detecting abnormal activity.
Methods: We accomplished this task by employing 12 recording electrodes. Three different doses of xylazine (0.5, 1 and 1.5 mg/kg) were used to determine which gave enough sedation to obtain a recording free of artifact. Fifty normal dogs were studied; for comparison 9 epileptic dogs were also explored.
Results: We found specific anatomical skull sites where the EEG recording electrodes should be attached; the location of these sites is, in practical terms, the same for every dog, regardless of their skull type. A dose of 1 mg/kg xylazine was chosen for restraining. Normal dogs displayed predominant 6-12 Hz waves which could be recognized all over the cortex. Epileptic dogs were individualized because of the appearance of paroxysmal discharges, composed of spikes, sharp and anomalous sinusoidal waves which usually started in one area, spreading to the whole cortex later on, in the clinical interictal periods.
Conclusions: It was possible to obtain more extensive electrophysiological coverage of the canine cerebral cortex, including the rhinencephalon and prorean gyrus, than previously described in the literature. Intramuscular or subcutaneous xylazine, at a dose of 1 mg/kg, proved to produce the best restraint for recordings. The technique allowed to distinguish abnormal activity in epileptic dogs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s1388-2457(03)00347-x | DOI Listing |
Epilepsia
January 2025
Equine and Companion Animal Nutrition, Department of Morphology, Imaging, Orthopedics, Rehabilitation, and Nutrition, Faculty of Veterinary Medicine, Ghent University, Ghent, Belgium.
Objective: Idiopathic epilepsy (IE) is the most common chronic neurological disease in dogs and an established natural animal model for human epilepsy types with genetic and unknown etiology. However, the metabolic pathways underlying IE remain largely unknown.
Methods: Plasma samples of healthy dogs (n = 39) and dogs with IE (n = 49) were metabolically profiled (n = 121 known target metabolites) and fingerprinted (n = 1825 untargeted features) using liquid chromatography coupled to mass spectrometry.
Vet Q
December 2025
Department of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
This review examines the role of the canine blood-brain barrier (BBB) in health and disease, focusing on the impact of the multidrug resistance (MDR) transporter P-glycoprotein (P-gp) encoded by the gene. The BBB is critical in maintaining central nervous system homeostasis and brain protection against xenobiotics and environmental drugs that may be circulating in the blood stream. We revise key anatomical, histological and functional aspects of the canine BBB and examine the role of the gene mutation in specific dog breeds that exhibit reduced P-gp activity and disrupted drug brain pharmacokinetics.
View Article and Find Full Text PDFAnimals (Basel)
December 2024
Department of Pharmacology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand.
Cannabidiol, the primary non-psychoactive phytocannabinoid found in cannabis, has generated significant research interest due to its potential for biological effects, such as anti-inflammatory, analgesic, immunomodulatory, and anticonvulsant properties. Several studies have demonstrated the potential of CBD to alter inflammatory cytokines; however, data on CBD's effects on cell viability and pro-inflammatory cytokines in target animals, such as dogs, are limited. Therefore, in this study, we investigated the effects of CBD on the cell viability and modulation of pro-inflammatory cytokines, such as interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α), in canine PBMCs stimulated with LPS.
View Article and Find Full Text PDFJ Am Anim Hosp Assoc
January 2025
From Veterinary Neurological Center "La Fenice," Selargius, Italy (I.T., F.T., A.G.).
An 8 yr old, male, mixed-breed dog was presented with a 2 mo history of progressive weakness, worsened in the last 2 days before examination. Neurological examination revealed ambulatory tetraparesis, ataxia, and proprioceptive deficits in all four limbs. Menace response was reduced in the right eye and discomfort was detected on neck manipulation.
View Article and Find Full Text PDFJ Vet Intern Med
December 2024
Division of Clinical Neurology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Background: In dogs with idiopathic epilepsy (IE), 33% develop resistance to conventional anti-seizure medication (ASM) despite adequate treatment. In human medicine, an immune-mediated etiology is suspected in a subset of ASM-resistant patients with epilepsy and cerebrospinal fluid (CSF)-specific immunoglobulin G (IgG)-type oligoclonal bands (OCBs) have been detected. In dogs, cases of autoimmune encephalitis recently were reported.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!